| Protocol Design | MOTS-c Dosing | 5-Amino-1MQ Dosing | Timing Strategy | Cycle Length | Best Suited For | Professional Assessment | ||||||| | Standard Metabolic Stack | 10mg subcutaneous, 3x/week (Mon/Wed/Fri) | 100mg oral, daily | MOTS-c AM fasted
1 Several studies have evaluated the differences in tendon strength and stress based on location
That is one extra dose worth of drug accumulation spread across the period
If the solution remains cloudy after gentle swirling and reaching room temperature, check your solvent
Not always, because better depends on your goal and how your skin reacts, and injections add more risk and more cost than a topical bottle
AOD-9604 is the most studied version: a Phase 2b obesity trial reported it was well tolerated with a safety profile comparable to placebo and no rebound weight gain, and it doesnt alter IGF-1 or glucose (BioSpace)